Trevena, Inc.

Trevena, Inc. logo
🇺🇸United States
Ownership
Public
Established
2007-01-01
Employees
23
Market Cap
$3.9M
Website
http://www.trevena.com
Clinical Trials
Related News

A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250

Phase 1
Terminated
Conditions
Migraines
Interventions
Drug: Placebo
First Posted Date
2019-12-17
Last Posted Date
2021-09-22
Lead Sponsor
Trevena Inc.
Target Recruit Count
9
Registration Number
NCT04201080
Locations
🇬🇧

MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence, Manchester, Greater Mancherster, United Kingdom

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty

Phase 3
Completed
Conditions
Acute Pain
Interventions
Drug: Placebo
Drug: Oliceridine
Drug: Morphine
First Posted Date
2016-06-30
Last Posted Date
2020-10-23
Lead Sponsor
Trevena Inc.
Target Recruit Count
407
Registration Number
NCT02820324
Locations
🇺🇸

Research Site, San Antonio, Texas, United States

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

Phase 3
Completed
Conditions
Acute Pain
Interventions
Drug: Oliceridine
Drug: Placebo
Drug: Morphine
First Posted Date
2016-06-28
Last Posted Date
2020-09-25
Lead Sponsor
Trevena Inc.
Target Recruit Count
418
Registration Number
NCT02815709
Locations
🇺🇸

Research Site, San Antonio, Texas, United States

🇺🇸

Resarch Site, Salt Lake City, Utah, United States

A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain

Phase 3
Completed
Conditions
Acute Pain
Interventions
Drug: TRV130
First Posted Date
2016-01-15
Last Posted Date
2020-09-24
Lead Sponsor
Trevena Inc.
Target Recruit Count
768
Registration Number
NCT02656875
Locations
🇺🇸

Recruiting, Murray, Utah, United States

A Pilot Study of TRV130 for the Treatment of Fracture Pain

Phase 2
Terminated
Conditions
Pain
Interventions
Drug: TRV130
First Posted Date
2015-08-11
Last Posted Date
2020-09-07
Lead Sponsor
Trevena Inc.
Target Recruit Count
1
Registration Number
NCT02520297
Locations
🇺🇸

Trevena, Inc., Indianapolis, Indiana, United States

A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: TRV734
First Posted Date
2015-04-08
Last Posted Date
2015-11-18
Lead Sponsor
Trevena Inc.
Target Recruit Count
18
Registration Number
NCT02411500

Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: TRV130
Drug: Moxifloxacin
Drug: Placebo
First Posted Date
2015-01-22
Last Posted Date
2017-05-12
Lead Sponsor
Trevena Inc.
Target Recruit Count
63
Registration Number
NCT02344303

A Study of TRV130 for the Treatment of Pain After Abdominoplasty

Phase 2
Completed
Conditions
Pain
Interventions
Drug: Morphine
Drug: TRV130
Drug: Placebo
First Posted Date
2015-01-09
Last Posted Date
2020-09-16
Lead Sponsor
Trevena Inc.
Target Recruit Count
200
Registration Number
NCT02335294

A Safety, Tolerability, PD and PK Study in Healthy Adults

First Posted Date
2014-08-07
Last Posted Date
2014-12-05
Lead Sponsor
Trevena Inc.
Target Recruit Count
75
Registration Number
NCT02211625
Locations
🇺🇸

ICON Development Solutions, San Antonio, Texas, United States

A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Radiolabeled TRV130
First Posted Date
2014-06-23
Last Posted Date
2015-11-18
Lead Sponsor
Trevena Inc.
Target Recruit Count
6
Registration Number
NCT02169934
Locations
🇺🇸

Madison Clinical Research Unit, Madison, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy